Your session is about to expire
← Back to Search
Procedure
Ablation for Liver Cancer
N/A
Recruiting
Led By Constantinos Sofocleous, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients diagnosed with secondary hepatic malignancy
Patients with confined liver disease or stable limited extrahepatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial is to study whether a particular test can show if the ablation worked in treating the tumor.
Who is the study for?
This trial is for adults with liver tumors no larger than 5cm, who aren't surgical candidates or prefer not to have surgery. They should have a stable blood clotting measure (INR<1.5), enough platelets, and either confined liver disease or limited stable disease outside the liver.Check my eligibility
What is being tested?
The study tests if analyzing tissue from ablated malignant liver metastases can predict treatment success. It involves CT-guided percutaneous ablation—a minimally invasive procedure—and examines whether new growths are cancerous post-treatment.See study design
What are the potential side effects?
While specific side effects are not listed here, percutaneous ablation procedures may include risks such as pain at the site of treatment, bleeding, infection, and damage to nearby organs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with cancer that has spread to my liver.
Select...
My cancer is mainly in my liver or is stable and not widely spread.
Select...
My cancer lesion is 5cm or smaller.
Select...
I am choosing a non-surgical treatment option instead of surgery.
Select...
My blood clotting time is within a safe range for a procedure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Tumor response
Secondary outcome measures
Duration of treatment response
Trial Design
1Treatment groups
Experimental Treatment
Group I: CT guided percutaneous ablationExperimental Treatment1 Intervention
The selected patients will undergo CT guided percutaneous ablation. The use of multi-tined electrode is encouraged, unless tumor location requires the use of an internally cooled needle electrode to eliminate injury to an adjacent vital structure or the operator prefers to use an internally cooled electrode for a specific reason.
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,937 Previous Clinical Trials
588,157 Total Patients Enrolled
20 Trials studying Liver Cancer
7,653 Patients Enrolled for Liver Cancer
Rockefeller UniversityOTHER
158 Previous Clinical Trials
16,227 Total Patients Enrolled
Constantinos Sofocleous, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: CT guided percutaneous ablation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers still enrolling participants for this experiment?
"This clinical trial remains open to participants, as evidenced by its listing on clinicaltrials.gov. This research was first made available back in October 2009 and has been updated more recently this April."
Answered by AI
What is the cap on enrollment for this research initiative?
"Affirmative. Clinicaltrials.gov records indicate that this medical trial, originally uploaded on October 27th 2009, is currently in recruitment mode and seeking 160 subjects at 1 different centre."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger